[Molecular Mechanism Study of One Case of Novel Allele of RhD Blood Group] [0.03%]
[RhD血型新等位基因分子机制研究]
Meng-Yuan Ding,Hui Zhang,Ming-Yuan Wang
Meng-Yuan Ding
Objective: To investigate the serological and genotypic characteristics of a novel allele of RhD blood group in a neonate. Methods: Ser...
[Gene Sequencing Analysis of 5 Patients with D Variant in Guangxi -Attached 1 Case of D Variant with New Allele] [0.03%]
广西5例D亚型地中海贫血基因序列分析及1例新突变DBeta-92A>G报告
Hui-Qiong Xie,Hui-Ni Huang,Hua-Li Huang et al.
Hui-Qiong Xie et al.
Objective: To assist the identification of clinical D variants using genetic testing technology. Methods: Five blood samples of patient...
[Analysis of HLA and HPA Antibody Specificity and Evaluation of HLA Antigen Immunogenicity in 90 Platelet Transfusion Refractory Patients in Changchun Region] [0.03%]
长春地区90例血小板输注无效患者HLA和HPA抗体特异性分析及供者抗原免疫原性评估
Ying Chen,Yu Han,Li Yan et al.
Ying Chen et al.
Objective: To detect HLA and HPA antibodies in patients with platelet transfusion refractoriness (PTR) in Changchun region, analyze their specificity, identify the major antibodies responsible for transfusion failure, and...
[Diversity of HPA Antigen-antibody and Its Application in Platelet Transfusion in Shenzhen Area] [0.03%]
深圳地区HPA抗原抗体多样性及其在血小板输注中的应用研究
Wen-Xia Xia,Fan Yang,Hua-Tao Che et al.
Wen-Xia Xia et al.
Objective: To investigate the polymorphism and genotype frequency of HPA gene in platelet donors in Shenzhen area, and to explore its application in clinical platelet transfusion. ...
[Changes and Clinical Significance of Blood Lipids in Patients with Myelodysplastic Syndrome] [0.03%]
骨髓增生异常综合征患者血脂变化及其临床意义分析
Li-Fa Wang,Xi-Jun Zhu
Li-Fa Wang
Objective: To analyze the changes of blood lipid levels in patients with myelodysplastic syndrome (MDS) and its clinical significance. Methods: ...
[Correlation between Peripheral Blood Immunological Markers and Gene Mutations in Myelodysplastic Syndrome] [0.03%]
[MDS患者外周血免疫学标志物与基因突变的相关性分析]
Da-Xiang Sun,Yun Ma,Qiu-Hong Han et al.
Da-Xiang Sun et al.
Objective: To explore the status of peripheral blood immunological markers and gene mutations in patients with myelodysplastic syndrome (MDS) and the correlation between them. ...
[Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1] [0.03%]
野生型SF3B1基因突变的MDS-RS患者临床特征及预后分析
Zhao-Wei Li,Feng Xu,Ling-Yun Wu et al.
Zhao-Wei Li et al.
Objective: To explore the clinical features and prognosis of myelodysplastic syndrome with ring sideroblasts (MDS-RS) patients with wild-type splicing factor 3B subunit 1 (SF3B1 ). ...
[Expression and Clinical Significance of SOCS1 and SOCS3 in Myelodysplastic Syndrome] [0.03%]
髓系肿瘤中SOCS1和SOCS3的表达及其临床意义分析
Yong-Xiao Zhang,Yan Wu,Rui Shi et al.
Yong-Xiao Zhang et al.
Objective: To investigate the expression levels of suppressor of cytokine signaling 1 ( SOCS1) and 3 (SOCS3) in patients with myelodysplastic syndrome (MDS) and assess their clinical significance. ...
[The Mechanism of Multiple Myeloma U266 Cell Exosome Circ- G042080 Promoting Multiple Myeloma Bone Disease through MiR-6791-3p/HDAC4 Axis] [0.03%]
外泌体Circ-G042080通过MiR-6791-3p/HDAC4轴促进多发性骨髓瘤骨病的机制研究
Jia-Qi Fu,Run-Jie Sun,Xing Cui
Jia-Qi Fu
Objective: To explore the mechanism of multiple myeloma cell exosome circRNA inducing osteoclast differentiation and promoting myeloma bone disease, and explore the feasibility of intervening myeloma bone disease by regul...
[A Single Center Real-World Study of the Efficacy of Daratumumab-Based Regimens in the Treatment of Relapsed/Refractory Multiple Myeloma Patients] [0.03%]
达托珠单抗为基础方案治疗复发难治多发性骨髓瘤患者疗效的单中心真实世界研究
Xiao-Mei Yang,Xiao-Ming Fei,Qi Yan et al.
Xiao-Mei Yang et al.
Objective: To evaluate the efficacy and safety of daratumumab-based regimens in the treatment of relapsed/refractory multiple myeloma patients at our center. ...